American Society of Hematology

Scholar Awards

The ASH Scholar Awards are designed to support hematologists who have chosen a career in research by providing partial salary or other support during that critical period required for completion of training and achievement of status as an independent investigator.

Read the ASH press release about the 2014 Scholar Award recipients.

Support

Awards are limited to a maximum of $100,000 for fellow scholars and $150,000 for junior faculty scholars over a two- to three-year period, with an annual maximum of $50,000 for fellows and $75,000 for junior faculty. Up to 15 percent of the award can be (but is not required to be) used for benefits, including medical and dental insurance, life insurance, and retirement benefits.

All awards are activated on July 1 of the following year. The applicant has the option of concluding the award on June 30, two or three years after activation. All award payments are made on a quarterly basis - the amount depends on whether the award is being spread over two or three years. Payments are made to the appropriate financial officer of the institution as indicated on the proposed budget within the full application.

back to top

Research Supported

Basic/Translational Research:

  • Basic Research:
    ASH considers basic research to include a broad spectrum of studies on genes, proteins, lipids, carbohydrates, biochemical and signaling pathways, receptors, cells and animals, as well as samples obtained from humans, all of which are designed to further our understanding of the blood, bone marrow, and related organs or the pathogenesis of blood disorders. The emphasis for grants in this category should be on the discovery of new knowledge in a traditional laboratory setting.
  • Translational Research:
    ASH defines translational research as using knowledge of human biology to develop and test the feasibility of relevant interventions in humans and/or determine the biological basis for observations made in individuals with hematologic conditions or in populations at risk. Translational research should be founded on and directly connected to some aspect of human biology and may encompass any form of structural, biochemical, genetic, or other appropriate experimental approaches using human materials. The proposal should address clinical applications - not just test development - although the development of novel instrumentation of value to hematology is clearly within the scope of the application. Clinical trial projects with laboratory correlatives are considered clinical.

Clinical Research: ASH considers clinical/translational research to include patient-oriented research and outcomes-based research. ASH emphasizes that clinical research must involve substantial interaction with patients.

  • Patient-Oriented Research
    For the purposes of the ASH Scholar Awards program, patient-oriented research is defined as research conducted with human subjects and involves an investigator directly interacting with human subjects. Categories of patient-oriented research include: 1) mechanisms of human disease, 2) therapeutic interventions, 3) clinical trials, and 4) development of new technologies.
  • Outcomes-Based Research
    ASH strongly encourages applications in outcomes-based research. Options for outcomes-based research include: 1) a decision-analysis or cost-effectiveness analysis of a relevant topic within hematology, 2) survey-based research investigating practice patterns, access to care, quality of care, clinical outcomes, or quality of life among patients with hematologic conditions, 3) retrospective analyses of large administrative databases (e.g., CMS, a large insurer, SEER) that may enlighten health care policy decisions related to hematologic disease, and 4) large scale epidemiologic or genetic epidemiologic studies that define the incidence, prevalence, prognosis, and natural history or the effects of therapy of blood disorders.

Applications that fall within any of the categories discussed above are encouraged.

back to top

Timeline

All ASH Scholar Award application eligibility notification emails sent out  Thursday, June 12, 2014
Application deadlineFriday, August 1, 2014
Award winners notifiedMid-November, 2014
Activation of awardWednesday, July 1, 2015
back to top

Eligibility Requirements

These eligibility requirements are evaluated as of the date of the LOI submission.

Citizenship

Eligible applicants must be a citizen of the United States or Canada or hold a visa in the United States or Canada.

Research

Eligible applicants must conduct research within the US or Canada

ASH Membership

Scholar Award applicants are required to be members of ASH in good standing at the time of the Letter of Intent submission, and for the duration of the Scholar Award Program. If your membership application is pending at the time of the Scholar Award application deadline, you will still be considered for a Scholar Award.

To verify your membership status, please log on to the membership section of the ASH website. If you need assistance with your username and password, please contact an ASH Customer Relations Representative at membership@hematology.org.

Fellow Scholar Awards

  • PhD or MD/PhD applicants must have fewer than 5 years of research experience after completion of their PhD (including research performed during fellowship, but excluding clinical fellowship time)
  • MD applicants should have more than 3 but fewer than 5 years of research experience (including research performed during fellowship, but excluding clinical fellowship time)
  • MD applicants with fewer than 3 years research experience (inclusive of fellowship research time) should consider applying for the Senior RTAF award
  • Applicants with the title of Assistant Professor or equivalent *must* apply for the Junior Faculty Award, regardless of research experience

Junior Faculty Scholar Awards

  • MD, PhD or MD/PhD applicants must have more than 5 but fewer than 10 years of research experience after completion of their PhD (including research performed during fellowship, but excluding clinical fellowship time)

Applicants with the title of Assistant Professor or equivalent *must* apply for the Junior Faculty Award, regardless of research experience.

back to top

Application Process

FAQs for Scholar Award Applicants

ASH requires applicants to submit a letter of intent form in order to be eligible to submit a full proposal. The letter of intent should include the following:

  • Letter of Intent online form
  • Abstract of proposed project (please do not exceed 350 words)
  • Applicant's curriculum vitae

ASH will perform a preliminary review of these materials to confirm eligibility and the appropriateness of the research category applied to. If additional information is required, ASH staff will contact you prior to June.

The full ASH Scholar Award applications will be available in early June only for those individuals who successfully submit a letter of intent by the deadline and are confirmed to be eligible.

Please be advised that your institution will be required to certify that at least 75 percent of your full-time professional effort is devoted to research.

back to top

Evaluation, Selection, and Notification

Anyone meeting the eligibility requirements set forth above can submit an application. The review of the scholar award applications is based solely on the scientific merit and quality of the applicant. However, in fairness to programmatic balance, no more than two awards will be granted per category (basic research fellow, basic research junior faculty, clinical/translational fellow, clinical/translational junior faculty) per medical school. For this purpose, ASH defines medical school so that it encompasses all sub-institutions (e.g., University of Washington would include the Fred Hutchinson Cancer Research Center, Children's Hospital, etc.).

Individuals selected to receive this award will be notified in mid-November.

back to top

Award Terms

Transfers

In the event the scholar transfers to another institution during the funding period, continuation of the funding at the new institution may be allowed with prior approval from the Society. To obtain permission, the scholar must make a request in writing to the Society before the transfer occurs.

Reallocation

Scholars may request a reallocation of funds from one expense category to another by submitting the request in writing to the Treasurer at the Society's headquarters. This written request must specify the dollar amount, which categories are impacted, and a justification as to why this change is necessary.

All transfer and/or rebudgeting requests must be sent to ASH Awards at awards@hematology.org, who will work with the ASH Treasurer to make final determinations.

Progress Reports

Scholar Award recipients are required to submit annual progress reports to the Society. The progress reports include a summary of the work performed and reprints of publications written by the scholar during the term of the award. This must be a two-page summary of the work accomplished in the first year of the award. This summary should be accompanied by a letter from the scholar's Division Head or Department Chair requesting the second year of funding. It should also provide assurances that the scholar's work has progressed and that both appropriate facilities and the scholar's mentor will continue to be available to the scholar. Failure to submit the progress report after the first year will render the scholar ineligible for the second year of funding. The recipients will be expected to cite support from the American Society of Hematology in any publication describing research conducted during the period of the award.

Final Reports

A final written report (not to exceed five pages) is expected within 30 days of the end of the award period. Scholar Award recipients, along with the financial officers from their institutions, must also submit a financial report detailing how the funds were used over the two- or three-year period. This report must be sent to ASH Awards at awards@hematology.org within 60 days of the end of the award period.

back to top

Joanne Levy, MD, Memorial Award for Outstanding Achievement

ASH is honored to offer the Joanne Levy, MD, Memorial Award for Outstanding Achievement as part of the ASH Scholar Awards program, a $3,500 grant, made possible by the Levy family to continue the legacy of their daughter, Joanne, a past ASH Scholar Award recipient and distinguished ASH member who passed away in 2004. Dr. Levy graduated from Harvard Medical School and went on to receive many prestigious awards and honors, including an NIH K08 award for research on the role of the transferrin receptor in erythropoiesis in 1996 before receiving an ASH Junior Faculty Scholar Award in 2000 for research on the genetic regulation of iron metabolism at Children's Hospital Boston.

This annual grant will automatically be awarded to the current ASH Scholar who has the highest scoring abstract for the ASH annual meeting as determined by the appointed abstract reviewers.back to top

History of the Scholar Awards

For many researchers, the period between completion of training and the establishment of one's independent career can be a perilous and uncertain time. Since 1985, the ASH Scholar Awards have helped ease this difficult transition for promising hematologists, allowing them to achieve their fullest potential. In 2009, ASH celebrated the 25th anniversary of the Scholar Awards program. Read the anniversary brochure to learn more past award winners and the significant milestones that mark the development and progress of this program.

Scholar Awards Brochure Image
Brochure: Celebrating the 25th Anniversary of the ASH Scholar Awards
back to top

Corporate Support

Visit ASH's Acknowledgement of Commercial Support page for more information on support for the ASH Scholar Awards.back to top

Questions

For more information about the ASH Scholar Awards program, please contact ASH at awards@hematology.org or by phone at 202-776-0544. back to top